We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Top Buys

1
TSEM icon
Tower Semiconductor
TSEM
+$9.09M
2
LITE icon
Lumentum
LITE
+$8.24M
3
GLW icon
Corning
GLW
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

1
CNC icon
Centene
CNC
+$9.07M
2
MOH icon
Molina Healthcare
MOH
+$8.9M
3
ELV icon
Elevance Health
ELV
+$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
401
Ionis Pharmaceuticals
IONS
$8.99B
– –
-7,807
Closed -$618K
IRON icon
402
Disc Medicine
IRON
$2.91B
– –
-1,780
Closed -$141K
IRWD icon
403
Ironwood Pharmaceuticals
IRWD
$635M
– –
-182,046
Closed -$613K
ISRG icon
404
CALL
Intuitive Surgical
ISRG
$122B
– –
-4
Closed -$401
ITGR icon
405
Integer Holdings
ITGR
$3.24B
– –
-4,075
Closed -$320K
JAZZ icon
406
CALL
Jazz Pharmaceuticals
JAZZ
$15.5B
– –
-283
Closed -$329K
JNJ icon
407
CALL
Johnson & Johnson
JNJ
$609B
– –
-133
Closed -$2.86K
KPTI icon
408
Karyopharm Therapeutics
KPTI
$216M
– –
-18,316
Closed -$140K
KTOS icon
409
CALL
Kratos Defense & Security Solutions
KTOS
$8.63B
– –
-10
Closed -$225
LEGN icon
410
CALL
Legend Biotech
LEGN
$4.31B
– –
-184
Closed -$2.76K
LGND icon
411
Ligand Pharmaceuticals
LGND
$6.08B
– –
-791
Closed -$150K
LI icon
412
Li Auto
LI
$12.3B
– –
-30,000
Closed -$508K
LNKB
413
DELISTED
LINKBANCORP
LNKB
– –
-67,578
Closed -$558K
LPLA icon
414
LPL Financial
LPLA
$26B
– –
-1,403
Closed -$501K
LPG icon
415
Dorian LPG
LPG
$1.76B
– –
-45,131
Closed -$1.1M
LQDA icon
416
Liquidia Corp
LQDA
$7.11B
– –
-10,536
Closed -$391K
LRCX icon
417
Lam Research
LRCX
$392B
– –
-3,061
Closed -$524K
LXEO icon
418
Lexeo Therapeutics
LXEO
$368M
– –
-16,025
Closed -$159K
MELI icon
419
Mercado Libre
MELI
$92B
– –
-10
Closed -$20.1K
MLTX icon
420
CALL
MoonLake Immunotherapeutics
MLTX
$1.64B
– –
-126
Closed -$30.3K
MLTX icon
421
MoonLake Immunotherapeutics
MLTX
$1.64B
– –
-8,523
Closed -$112K
MNKD icon
422
CALL
MannKind Corp
MNKD
$1.25B
– –
-1,490
Closed -$8.93K
MOH icon
423
Molina Healthcare
MOH
$11.7B
– –
-51,285
Closed -$8.9M
MREO
424
CALL
Mereo BioPharma
MREO
$49.5M
– –
-5,359
Closed -$57
MRK icon
425
Merck
MRK
$315B
– –
-3,471
Closed -$401K
15 16
17
18 19

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.